1-(4,6-Dimethylpyrimidin-2-yl)piperidine-4-carboxamide

Catalog No. :
ACMZNO641
CAS No. :
792940-20-6
Molecular Formula :
C12H18N4O
Molecular Weight :
234.30

IUPAC Name:1-(4,6-dimethylpyrimidin-2-yl)piperidine-4-carboxamide

1-(4,6-Dimethylpyrimidin-2-yl)piperidine-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$88.00Login to see priceInquiryInquiry
250mg97%$149.00Login to see priceInquiryInquiry
1g97%$404.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4,6-Dimethylpyrimidin-2-yl)piperidine-4-carboxamide
IUPAC Name1-(4,6-dimethylpyrimidin-2-yl)piperidine-4-carboxamide
MDL No.MFCD06617674
Molecular FormulaC12H18N4O
Molecular Weight234.30
SMILESO=C(C1CCN(C2=NC(C)=CC(C)=N2)CC1)N
InChI KeyXELPGXYIOBXPST-UHFFFAOYSA-N
Synonym1-(4,6-DIMETHYLPYRIMIDIN-2-YL)PIPERIDINE-4-CARBOXAMIDE;1-(4,6-Dimethyl-2-pyrimidinyl)-4-piperidinecarboxamide;4-Piperidinecarboxamide, 1-(4,6-dimethyl-2-pyrimidinyl)-
CAS No.792940-20-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACMZNO641 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACMZNO641 route product structure diagram
    ACMZNO641792940-20-6
Inquiry

2. ACMZNO641 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACMZNO641 route product structure diagram
    ACMZNO641792940-20-6
Inquiry

Comments (0)